financetom
Business
financetom
/
Business
/
Century Therapeutics Shares Rise After Q3 Beats Estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Century Therapeutics Shares Rise After Q3 Beats Estimates
Nov 7, 2024 9:19 PM

12:11 PM EST, 11/05/2024 (MT Newswires) -- Century Therapeutics ( IPSC ) shares were up more than 8% in recent Tuesday trading after the company reported Q3 results that beat market expectations.

The firm posted a Q3 net loss of $0.37 per diluted share, narrowing from $0.55 loss a year ago. Analysts polled by Capital IQ expected $0.45 loss per share.

Revenue for the quarter ended Sept. 30 was $791,000, compared with $148,000 a year earlier. Analysts polled by Capital IQ expected $550,000.

The company said it expects its funds will support operations into the H2 of 2026.

Price: 1.37, Change: +0.11, Percent Change: +8.33

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved